National Shingles Vaccination Program
One in three people will develop shingles in their lifetime, with the risk of complications increasing with age. Herpes zoster (shingles) vaccination is recommended and has been funded from 1 November 2016 for eligible people under the National Immunisation Program. Shingles immunisation can significantly reduce the risk of developing shingles and the associated ongoing persistent pain known as postherpetic neuralgia (PHN) .
Eligible for free vaccine
A single dose of the shingles vaccine, Zostavax ®, is free for people aged 70 years of age. The program also includes a five year catch-up program for people aged 71 – 79 years until 31 October 2021.
Recommended but not funded
The shingles vaccine can be administered from the age of 50 years of age, and may be recommended for individuals with chronic medical conditions who may be at higher risk of complications from the shingles infection. Speak to you doctor for further information.
People who are not eligible to receive the free vaccine are able to purchase the vaccine on the private market.
Accessing the vaccine
To receive the free shingles vaccine, speak to your doctor. For further information on immunisation providers, see the Immunisation services page.
For further information on the National Shingles Vaccination Program contact your local doctor or immunisation provider.